SARTORELLO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.926
AS - Asia 1.396
EU - Europa 685
SA - Sud America 246
AF - Africa 244
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 5.524
Nazione #
US - Stati Uniti d'America 2.810
SG - Singapore 462
CN - Cina 254
VN - Vietnam 239
BR - Brasile 153
HK - Hong Kong 131
IT - Italia 94
FI - Finlandia 69
DE - Germania 57
FR - Francia 57
GB - Regno Unito 52
SE - Svezia 50
BD - Bangladesh 40
PL - Polonia 34
IN - India 33
TR - Turchia 26
NL - Olanda 23
RU - Federazione Russa 23
UA - Ucraina 21
EC - Ecuador 20
CA - Canada 19
IQ - Iraq 19
PK - Pakistan 19
AR - Argentina 17
ZA - Sudafrica 17
CI - Costa d'Avorio 16
ES - Italia 16
MX - Messico 16
PH - Filippine 14
BE - Belgio 13
IE - Irlanda 12
LA - Repubblica Popolare Democratica del Laos 12
BJ - Benin 11
CO - Colombia 11
EG - Egitto 11
JP - Giappone 11
AT - Austria 10
BF - Burkina Faso 10
BY - Bielorussia 10
CL - Cile 10
PT - Portogallo 10
YT - Mayotte 10
AZ - Azerbaigian 9
DZ - Algeria 9
HR - Croazia 9
JM - Giamaica 9
ME - Montenegro 9
PE - Perù 9
AD - Andorra 8
AE - Emirati Arabi Uniti 8
AO - Angola 8
EE - Estonia 8
IL - Israele 8
IS - Islanda 8
MA - Marocco 8
MG - Madagascar 8
MN - Mongolia 8
NO - Norvegia 8
PF - Polinesia Francese 8
RE - Reunion 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
LV - Lettonia 7
RS - Serbia 7
SA - Arabia Saudita 7
SK - Slovacchia (Repubblica Slovacca) 7
TN - Tunisia 7
UG - Uganda 7
CY - Cipro 6
DJ - Gibuti 6
ET - Etiopia 6
GN - Guinea 6
ID - Indonesia 6
IR - Iran 6
KE - Kenya 6
KG - Kirghizistan 6
KR - Corea 6
LC - Santa Lucia 6
LU - Lussemburgo 6
PR - Porto Rico 6
PY - Paraguay 6
RO - Romania 6
ZW - Zimbabwe 6
AL - Albania 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
BZ - Belize 5
CH - Svizzera 5
CR - Costa Rica 5
CV - Capo Verde 5
CW - ???statistics.table.value.countryCode.CW??? 5
DK - Danimarca 5
DM - Dominica 5
GH - Ghana 5
GM - Gambi 5
GR - Grecia 5
HN - Honduras 5
HU - Ungheria 5
JO - Giordania 5
KZ - Kazakistan 5
Totale 5.324
Città #
Ashburn 471
San Jose 376
Fairfield 308
Singapore 272
Chandler 154
Houston 133
Hong Kong 118
Cambridge 115
Woodbridge 114
Seattle 105
Ann Arbor 84
Wilmington 79
Ho Chi Minh City 68
Santa Clara 58
Jacksonville 57
Los Angeles 55
Dong Ket 50
Hanoi 44
Beijing 43
Princeton 40
Boardman 35
New York 33
Helsinki 31
Lauterbourg 27
San Diego 25
Buffalo 23
São Paulo 19
Munich 18
Bytom 17
Nanjing 17
Washington 17
Abidjan 16
Medford 16
Orem 15
Council Bluffs 14
Chicago 12
London 12
Padova 12
Roxbury 12
Cotonou 11
Dublin 11
Johannesburg 11
Turku 11
Warsaw 11
Changsha 10
Dallas 10
Stockholm 10
Vientiane 10
Baghdad 9
Milan 9
Minsk 9
Baku 8
Hefei 8
The Dalles 8
Ulan Bator 8
Andorra la Vella 7
Denver 7
Des Moines 7
Frankfurt am Main 7
Kampala 7
Papeete 7
Podgorica 7
Reykjavik 7
Shenyang 7
Tallinn 7
Addis Ababa 6
Antananarivo 6
Atlanta 6
Brooklyn 6
Cairo 6
Conakry 6
Da Nang 6
Guayaquil 6
Harare 6
Hebei 6
Lahore 6
Madrid 6
Nairobi 6
Ouagadougou 6
Redondo Beach 6
Tianjin 6
Tokyo 6
Amman 5
Bamako 5
Banjul 5
Buenos Aires 5
Bắc Ninh 5
Castries 5
Chennai 5
Dar es Salaam 5
Jeddah 5
Karachi 5
Kigali 5
Managua 5
Montreal 5
Norwalk 5
Nuremberg 5
Quito 5
Riga 5
Roseau 5
Totale 3.531
Nome #
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 298
A new L1446P mutation is responsible for impaired von Willebrand factor synthesis, structure, and function. 262
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 254
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 251
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 242
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 239
Higher and lower active circulating VWF levels: different facets of von Willebrand disease 237
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 233
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 233
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 227
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 221
Microsatellite (GT)(n) repeats and SNPs in the von Willebrand factor gene promoter do not influence circulating von Willebrand factor levels under normal conditions. 213
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 198
Multiple von Willebrand factor mutations in patients with recessive type 1 von Willebrand disease. 195
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 194
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 192
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 192
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 183
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 181
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 180
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 171
Haplotypes of Von Willebrand factor promoter predict thrombotic risk in Cushing's syndrome 169
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 167
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 162
Which assay is the most suitable to investigate von Willebrand factor functional activity? 153
Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding. 152
Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor. 105
Antiphosphatidylserine/prothrombin antibodies define a high-risk antiphospholipid syndrome profile associated with organ damage 42
Totale 5.546
Categoria #
all - tutte 16.710
article - articoli 16.284
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022364 16 29 70 18 6 29 16 43 10 6 53 68
2022/2023297 56 38 7 30 57 31 2 18 37 3 18 0
2023/2024205 2 27 32 17 29 38 20 3 1 7 18 11
2024/2025664 1 50 42 36 91 26 30 33 53 24 116 162
2025/20262.893 134 212 355 437 232 110 487 234 350 159 114 69
2026/202737 37 0 0 0 0 0 0 0 0 0 0 0
Totale 5.546